Laurus Labs Q4 results

the Hyderabad-based active pharmaceutical ingredients maker, on Thursday, April 24, reported consolidated net profit of ₹234 crore in quarter ended March 2025, marking an increase of 3.09 times from ₹75.61 crore in the same period last year. The sharp jump in profit in fourth quarter of financial year 2025 came on the back of improvement in operating profit margin of the company. Laurus Labs operating profit also known as earnings before interest, taxes, depreciation, and amortisation (EBITDA) improved by 783 basis points to 24.71% as against 16.77% in the year-ago period. The company's EBITDA came in at ₹420 crore, up 74% from ₹241 crore the corresponding period last financial year.